Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $454.15 | 12 | 90.5% |
| Education | $47.95 | 1 | 9.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $144.61 | 3 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $130.19 | 2 | $0 (2020) |
| GlaxoSmithKline, LLC. | $110.64 | 1 | $0 (2019) |
| Philips Electronics North America Corporation | $47.90 | 3 | $0 (2023) |
| Edwards Lifesciences Corporation | $20.02 | 1 | $0 (2018) |
| Teleflex LLC | $18.26 | 1 | $0 (2023) |
| Baxter Healthcare | $17.34 | 1 | $0 (2021) |
| Philips North America LLC | $13.14 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.14 | 1 | Philips North America LLC ($13.14) |
| 2023 | $66.16 | 4 | Philips Electronics North America Corporation ($47.90) |
| 2021 | $17.34 | 1 | Baxter Healthcare ($17.34) |
| 2020 | $160.04 | 2 | AstraZeneca Pharmaceuticals LP ($112.09) |
| 2019 | $128.74 | 2 | GlaxoSmithKline, LLC. ($110.64) |
| 2018 | $99.72 | 2 | Genentech USA, Inc. ($79.70) |
| 2017 | $16.96 | 1 | Genentech USA, Inc. ($16.96) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $13.14 | General |
| Category: Medical Device | ||||||
| 10/26/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $19.68 | General |
| Category: Medical Device | ||||||
| 10/26/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $15.15 | General |
| Category: Medical Device | ||||||
| 10/17/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $13.07 | General |
| Category: Medical Device | ||||||
| 10/02/2023 | Teleflex LLC | ARROW (Device) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Emergency Medicine | ||||||
| 12/08/2021 | Baxter Healthcare | STARLING SYSTEM (Device) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Fluid Systems | ||||||
| 03/05/2020 | Genentech USA, Inc. | Esbriet (Biological) | Education | In-kind items and services | $47.95 | General |
| Category: Immunology | ||||||
| 01/29/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $112.09 | General |
| Category: Respiratory | ||||||
| 11/05/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $110.64 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Respiratory | ||||||
| 11/29/2018 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $20.02 | General |
| 02/22/2018 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $79.70 | General |
| Category: Immunology | ||||||
| 08/09/2017 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 790 | 1,087 | $257,915 | $139,433 |
| 2022 | 12 | 898 | 1,279 | $322,015 | $170,862 |
| 2021 | 10 | 807 | 1,165 | $295,605 | $159,397 |
| 2020 | 13 | 896 | 1,326 | $322,870 | $174,958 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 286 | 472 | $148,680 | $84,326 | 56.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 295 | 403 | $62,465 | $40,031 | 64.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 68 | 69 | $17,250 | $9,464 | 54.9% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 27 | 27 | $8,100 | $3,292 | 40.6% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 19 | 20 | $7,500 | $1,438 | 19.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 26 | 26 | $4,160 | $253.84 | 6.1% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 17 | 18 | $1,440 | $220.90 | 15.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 26 | 26 | $4,160 | $218.22 | 5.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 26 | 26 | $4,160 | $189.63 | 4.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 359 | 658 | $207,270 | $120,510 | 58.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 286 | 365 | $56,575 | $30,677 | 54.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 60 | 61 | $15,250 | $9,426 | 61.8% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 36 | 37 | $11,100 | $4,524 | 40.8% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 34 | 34 | $12,750 | $2,454 | 19.2% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 11 | 11 | $2,750 | $1,005 | 36.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $2,360 | $912.03 | 38.6% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2022 | 13 | 13 | $2,600 | $485.34 | 18.7% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2022 | 35 | 36 | $2,880 | $411.74 | 14.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 18 | 18 | $2,880 | $178.63 | 6.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 17 | 17 | $2,720 | $145.04 | 5.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 18 | 18 | $2,880 | $133.50 | 4.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 342 | 627 | $197,505 | $117,107 | 59.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 226 | 296 | $45,880 | $25,576 | 55.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 39 | 39 | $9,750 | $6,399 | 65.6% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2021 | 31 | 32 | $9,600 | $4,032 | 42.0% |
About Dr. Beth Ginsburg, MD
Dr. Beth Ginsburg, MD is a Pulmonary Disease healthcare provider based in Forest Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932279031.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beth Ginsburg, MD has received a total of $502.10 in payments from pharmaceutical and medical device companies, with $13.14 received in 2024. These payments were reported across 13 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($454.15).
As a Medicare-enrolled provider, Ginsburg has provided services to 3,391 Medicare beneficiaries, totaling 4,857 services with total Medicare billing of $644,650. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Forest Park, IL
- Active Since 11/08/2006
- Last Updated 01/19/2012
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1932279031
Products in Payments
- Esbriet (Biological) $144.61
- FASENRA (Drug) $130.19
- TRELEGY ELLIPTA (Drug) $110.64
- (8874) inCourage (Device) $47.90
- ARROW (Device) $18.26
- STARLING SYSTEM (Device) $17.34
- (AK6) Vest Therapy (Device) $13.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.